Can a US pharmaceutical company own an Indian subsidiary?

A US company may be able to establish an Indian subsidiary, but the applicable foreign-investment route and conditions depend on the proposed activity and current policy. Confirm the rules for the actual business model before investing.

Does company incorporation allow a medicine to be sold in India?

No. Incorporation does not replace product approvals, import permissions, manufacturing licences or applicable sale and distribution licences. Requirements depend on the product and activity.

Will every pharmaceutical product be subject to the same price controls?

No. Check the applicable drug price-control framework and current NPPA orders for the specific formulation and product. Do not assume one price rule applies to every medicine.

Should the company manufacture locally or import from the US?

Compare product approvals, landed cost, customs, lead times, quality requirements, supply reliability, investment and customer expectations. Contract manufacturing may be another option, but responsibilities and licences must be checked.

What should be agreed with an Indian distributor or contract manufacturer?

Define product and territory scope, licence responsibilities, quality systems, storage and distribution standards, safety reporting, recalls, audit rights, IP, confidentiality, payment terms and termination support.

AU CorporateGrowing Together

English

US to India · Pharmaceuticals and medicines

Setting Up an Indian Subsidiary for a US Pharmaceutical Company

A US pharmaceutical company may enter India through imports and distribution, local manufacturing, contract manufacturing, research or a combination of activities. These models can involve different product permissions, licensing, pricing, supply-chain and compliance requirements. Define the products and the Indian entity’s role before choosing the operating structure.

Prepared by AU Corporate's CA-led advisory team · Published 13 October 2026 · General guidance; confirm current rules and product-specific requirements before acting.

Quick answer

What should a US pharmaceutical company check before entering India?

Identify each medicine and the planned activity: importing, marketing, distributing, manufacturing, contract manufacturing or conducting research. Check the relevant CDSCO pathway, state licensing requirements, applicable pricing controls, current foreign-investment policy, product labelling, pharmacovigilance, import and tax treatment. Incorporation does not itself authorise a medicine to be imported, manufactured or sold.

1. Choose the India operating model

Decide whether the Indian company will hold product permissions, import finished medicines, market products through a licensed partner, manufacture locally, use a contract manufacturer or provide research services. Clarify which entity will hold licences, release products, manage safety reports and contract with distributors or hospitals.

List each product, dosage form and proposed activity separately.
Decide who will be the importer, licence holder, marketer and safety contact.

2. Confirm product and establishment permissions

Review the applicable Central Drugs Standard Control Organisation (CDSCO) pathway for the product and proposed activity. Import, new-drug approval, clinical research and manufacturing can involve different requirements. State drug-control authorities may also be relevant for manufacturing, sale or distribution licences. Do not assume one approval covers every product or location.

Map the product-specific requirements before setting launch dates.
Check whether local manufacturing or distribution requires additional state-level licences.

3. Review pricing, labelling and promotion

Check whether a product falls within applicable drug price-control rules and review current National Pharmaceutical Pricing Authority (NPPA) orders where relevant. Confirm pack labelling, prescribing information, approved claims, promotional materials and distribution practices against applicable rules and product permissions.

Check price-control status product by product.
Have local regulatory specialists review packaging and marketing claims.

4. Assess manufacturing and supply-chain options

Compare importing finished products, contract manufacturing and building a local facility. Include customs and logistics, temperature control, quality agreements, batch release, product traceability, recalls, supplier audits and business continuity. Manufacturing can require a separate facility, quality and licensing workstream.

Model landed cost, lead times and inventory risks.
Agree quality responsibilities, deviations, complaints and recalls with partners.

5. Protect regulatory dossiers and intellectual property

Document ownership and permitted use of dossiers, formulations, trademarks, manufacturing know-how, clinical data and safety information. Put confidentiality, data access, local partner responsibilities, change control and exit arrangements in writing.

Limit access to confidential technical and regulatory files.
Set ownership and transfer rules for new data and improvements.

6. Plan investment, tax and intercompany arrangements

Check current FDI conditions for the exact activity and ownership. Document parent funding, technology or trademark licences, contract manufacturing, distribution and support services. Review customs, GST, withholding and transfer pricing based on the actual transactions and agreements.

Keep agreements and invoices aligned with actual goods and services.
Plan working capital for inventory, regulatory costs and distributor payment terms.

7. Build the compliance calendar before launch

Plan company-law filings, accounting, audit, tax, payroll and foreign-investment reporting alongside product renewals, quality records, safety reporting, licence conditions and regulatory change monitoring.

Assign a responsible owner for each recurring requirement.
Keep a record of product approvals, variations, complaints and safety actions.

Official sources to check

Use official sources to confirm current requirements for the product, activity and route to market. Licensing and compliance obligations may differ by product, business activity and location.

Related guides

AU Corporate can help map India-side incorporation, tax and ongoing compliance workstreams to the proposed operating model.

This article is general information, not legal, tax, regulatory or investment advice. Rules can change; confirm current requirements before making business decisions.